IPO Profile: Aduro BioTech Inc

The drug developer raised venture funding from Johnson & Johnson and OrbiMed, among others

1 May 2015•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.